Accessibility settings

This paper is in the following e-collection/theme issue:

Telehealth and Telemonitoring (3009) Web-based and Mobile Health Interventions (5749) Depression and Mood Disorders; Suicide Prevention (2405) Posttraumatic Stress Disorder (PTSD) (190) Anxiety and Stress Disorders (1586) Telepsychiatry (272)

Published on in Vol 28 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/92647, first published .
Person in VR headset rests in armchair; tablet, vial, and syringe on table.

At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study

At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study

Authors of this article:

Acacia C Parks1 Author Orcid Image ;   Amanda L Woodward1 Author Orcid Image ;   Robert D Henry2, 3 Author Orcid Image ;   Kristin A Arden4 Author Orcid Image ;   Leonardo Vando4 Author Orcid Image ;   Jack Swain4 Author Orcid Image ;   Bishal Lamichhane5 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.